Franziska Modemann

Dr. Franziska Modemann is a Clinical Assistant Professor at the University Medical Center Hamburg-Eppendorf (UKE), affiliated with the Faculty of Medicine. She holds a Medical Specialist certification in Internal Medicine, Hematology, and Oncology, working within the II. Medical Clinic and Polyclinic under the Center for Oncology. Her clinical practice focuses on hematological malignancies, particularly acute leukemias, and she actively engages in translational research addressing treatment efficacy, immunotherapeutic strategies, and clinical outcomes in oncology.

Her research interests span precision medicine approaches in acute myeloid leukemia (AML), immunotherapy development using CAR-T cells, and leveraging machine learning for automated diagnostic systems. She contributes to global clinical trials evaluating novel drug combinations and has published extensively on AML prognosis modeling, drug response patterns, and immunological mechanisms in hematologic malignancies.

Modemann's work frequently addresses clinical challenges such as gastrointestinal toxicity in targeted therapies and complications in hematologic emergency surgeries. She collaborates across disciplines, integrating molecular profiling with clinical decision-making to improve patient outcomes.

Her publications analyze over 150 cases from multi-center studies, exploring topics like donor-transmitted leukemia in transplant recipients and hepatitis E management in immunocompromised patients. She maintains an active presence in medical education through guideline development and case study analyses, emphasizing practical applications of research findings in clinical settings.

Modemann is trilingual (German, English, French), enhancing her capacity to engage with international collaborators and patients. Her academic contributions are supported by the UKE's advanced research infrastructure, including access to clinical trial networks and translational medicine platforms.